Unimed-Rio continues its positive review by Fitch Ratings | SEGS

The operator maintains BB + rating and enhances growth prospects

RIO DE JANEIRO, September 15, 2021 – Unimed-Rio maintained its BB+ rating in the report of Fitch Ratings, an international risk assessment agency, released last Thursday (9). The score reflects continuous improvement in operator process management and reinforces the positive outlook in the evaluation.

Since 2016, when it was rated in Class C, Unimed-Rio has grown by eight places. According to Fitch’s ratings, the assessment takes into account positive points such as the expectation to resume operating cash generation for the cooperative from 2022, reductions in financial and regulatory exposure, and maintaining an adequate liquidity profile.

For the evaluation, the operating practices of Unimed-Rio were analyzed, and the result reflects the level of quality that the company occupies. In addition to providing greater transparency to the operator’s business, the rating magnifies the cooperative’s good image in the community, with the potential to attract new investors.

About Unimed-Rio

With 49 years, Unimed-Rio is part of the largest private health system in Latin America, with about 5 thousand collaborating physicians and a portfolio of more than 800,000 clients under its assistance. With a market share of 15.3%, the cooperative leads the market in Rio de Janeiro and is among the three health insurance brands favored by Cariocas, according to O Globo newspaper. It’s the seventh best operating company in the state of Rio, according to Great Place to Work.